Immune system irregularities called autoimmune diseases phenomenon are those where the immune system, which by design should protect the body from the outside attack, makes an abnormal production of antibodies that not only fail to protect but also directly attack the healthy cells and tissues of the body, therefore, cause their damage and decay. Globally, there are almost 80 different types of such diseases, with the main ones being, besides others, the rheumatoid arthritis and system lupus erythematosus. The data from the American Autoimmune Related Diseases Association (AARDA) says that these diseases are the cause of health problems for almost 50 million people in the U.S., and 75% of the cases i.e. women account the largest part. Often diagnosis is done through the following lab tests: autoantibody tests, complete blood count, antinuclear antibody tests, C-reactive protein, and erythrocyte sedimentation rate.
Key Growth Drivers and Opportunities
Growing Awareness About Autoimmune Diseases: One of the main factors leading to the global acceptance of diagnostics for autoimmune diseases is the awareness that the cases are rising that has been created through education, research, advocacy, and support programs. The U.S. tops the list of countries with the highest number of cases, with a total of over 50 million patients, out of which 54.4 million cases of arthritis were recorded in 2017. Both non-governmental organizations and government agencies are continuously pointing to the severe negative economic impact of autoimmunity that can only be reversed by collaboration and patient-centered actions.
Challenges
The market for diagnosing autoimmune diseases is constrained by several factors including the high costs of diagnostic tests, absence of standardized diagnostic methods, the possibility of false-positive results or incorrect diagnosis due to similar symptoms, and low awareness in underdeveloped areas, which together impede both timely and correct diagnosis.
Innovation and Expansion
Progentec Diagnostics Introduces CareMGMT(TM), an Innovative App that Offers a Unified Experience for those with Autoimmune Conditions
In August 2024, Progentec Diagnostics, Inc., a pioneer in autoimmune illness diagnostic and digital technologies, today announced the release of CareMGMT, a game-changing app that allows people to take charge of their autoimmune health.
CareMGMT offers a variety of tools designed to help people on their health journeys, such as thorough symptom tracking, autoimmune-related research news and updates, individualized health insights, and a safe and supportive community board.
NeoDx Biotech Labs Releases an IVD kit for Detecting Autoimmune Illnesses
In September 2023, NeoDx Biotech Labs, a Bengaluru-based firm, has introduced a Real-time PCR-Technology-based in vitro diagnostic (IVD) kit for Ankylosing Spondylitis, enabling healthcare providers to expand testing capabilities.
The HLA-B27 RT-PCR detection kit for Exon 2/Exon 3 is used to detect Human Leukocyte Antigen B27 in whole blood. The inflammatory illnesses Ankylosing Spondylitis (AS), Psoriasis, Inflammatory Bowel Disease, and Reactive Arthritis are strongly linked to HLA-B27. HLA-B27 testing can help in the early diagnosis and treatment of several disorders.
Inventive Sparks, Expanding Markets
The key players operating the autoimmune disease diagnosis market includes Thermo Fisher Scientific, Siemens Healthcare Private Limited, Hoffmann-La Roche Ltd., Abbott Laboratories, Beckman Coulter, Inc., SQI Diagnostics Inc., Quest Diagnostics, EUROIMMUN AG, INOVA Diagnostics, Inc., and Bio-Rad Laboratories, Inc.
About Author:
Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.
